Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21799375 | 0.72 | — | — | |
| SCHEMBL5174800 | 0.70 | — | — | |
| SCHEMBL4104006 | 0.68 | SLC22A6 (0.43) | SLC22A6 | |
| SCHEMBL3726700 | 0.67 | SLC22A6 (0.34) | SLC22A6 | |
| SCHEMBL16174829 | 0.66 | SLC22A6 (0.42) | SLC22A6 | |
| SCHEMBL16174873 | 0.66 | SLC22A6 (0.42) | SLC22A6 | |
| SCHEMBL1627316 | 0.65 | — | — | |
| SCHEMBL28779546 | 0.65 | SLC22A6 (0.37) | SLC22A6 | |
| SCHEMBL16109726 | 0.65 | SLC22A6 (0.37) | SLC22A6 | |
| SCHEMBL4546739 | 0.65 | SLC22A6 (0.37) | SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7682602-B2 | Near-infrared fluorescent contrast medium | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2010-03-23 | — | — | US | disclosed |
| EP-1695960-A1 | NEAR-INFRARED FLUORESCENT CONTRAST MEDIUM | Konica Minolta Medical & Graphic, Inc. (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20050136007-A1 | Near-infrared fluorescent contrast medium | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2005-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136007-A1 | Near-infrared fluorescent contrast medium | NEFM, IK, MYADM | SLC22A6 254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.